Analysts think VYGR stock price could increase by 314%
Apr 07, 2025, 11:25 AM
5.03%
What does VYGR do
Voyager Therapeutics, a clinical-stage gene therapy company based in Lexington, Massachusetts, focuses on developing treatments for severe neurological diseases, including Alzheimer's and ALS. Founded in 2015, it employs 162 people and utilizes its TRACER AAV platform for therapy development.
10 analysts think VYGR stock price will increase by 313.96%. The current median analyst target is $12.75 compared to a current stock price of $3.08. The lowest analysts target is $9.09 and the highest analyst target is $18.90.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
